139 related articles for article (PubMed ID: 2358732)
1. Transient hyperprolactinemia has no effect on endocrine response and outcome in in vitro fertilization (IVF).
Pattinson HA; Taylor PJ; Fleetham JA; Servis SA
J In Vitro Fert Embryo Transf; 1990 Apr; 7(2):89-93. PubMed ID: 2358732
[TBL] [Abstract][Full Text] [Related]
2. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
Sudik R; Fliess FR; Kunkel S
Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
[TBL] [Abstract][Full Text] [Related]
3. Transient hyperprolactinemia in gonadotropin-stimulated cycles for in vitro fertilization and its effect on conception.
Chang SP; Ng HT; Lan TL; Chao HT; Wei TC; Yang TS; Ou-Yang XR
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jun; 51(6):401-6. PubMed ID: 8281485
[TBL] [Abstract][Full Text] [Related]
4. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
Balasch J; Creus M; Fábregues F; Carmona F; Casamitjana R; Peñarrubia J; Rivera F; Vanrell JA
Gynecol Endocrinol; 1995 Mar; 9(1):51-8. PubMed ID: 7793300
[TBL] [Abstract][Full Text] [Related]
5. The incidence of transient hyperprolactinemia in gonadotropin-stimulated cycles for in vitro fertilization and its effect on pregnancy outcome.
Hofmann GE; Denis AL; Scott RT; Muasher SJ
Fertil Steril; 1989 Oct; 52(4):622-6. PubMed ID: 2806600
[TBL] [Abstract][Full Text] [Related]
6. Treatment versus no treatment of transient hyperprolactinemia in patients undergoing intracytoplasmic sperm injection programs.
Doldi N; Papaleo E; De Santis L; Ferrari A
Gynecol Endocrinol; 2000 Dec; 14(6):437-41. PubMed ID: 11228065
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between serum prolactin secretion patterns and the ability of fertilization and cleavage of human oocyte (effects of transient hyperprolactinemia on fertilization and cleavage of human oocyte)].
Azuma K; Yamano S
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2097-106. PubMed ID: 4078410
[TBL] [Abstract][Full Text] [Related]
8. Effects of clomiphene citrate and leuprolide acetate on luteal-phase hyperprolactinemia during ovarian stimulation with menopausal gonadotropins.
Kaplan CR; Koong MK; Olive DL; Riehl RM; Burns WN; Groff TR; Schenken RS
J In Vitro Fert Embryo Transf; 1991 Dec; 8(6):308-13. PubMed ID: 1770270
[TBL] [Abstract][Full Text] [Related]
9. The influence of transient hyperprolactinemia on hormonal parameters, oocyte recovery, and fertilization rates in in vitro fertilization.
Gonen Y; Casper RF
J In Vitro Fert Embryo Transf; 1989 Jun; 6(3):155-9. PubMed ID: 2794732
[TBL] [Abstract][Full Text] [Related]
10. Transient hyperprolactinemia during cycle stimulation and its influence on oocyte retrieval and fertilization rates.
Hummel WP; Clark MR; Talbert LM
Fertil Steril; 1990 Apr; 53(4):677-81. PubMed ID: 2108058
[TBL] [Abstract][Full Text] [Related]
11. Transient hyperprolactinemia during cycle stimulation: influence on the endocrine response and fertilization rate of human oocytes and effects of bromocriptine treatment.
Reinthaller A; Bieglmayer C; Deutinger J; Csaicsich P
Fertil Steril; 1988 Mar; 49(3):432-6. PubMed ID: 3342894
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine inhibition of anesthesia-induced hyperprolactinemia: effect on serum and follicular fluid hormones, oocyte fertilization, and embryo cleavage rates during in vitro fertilization.
Sopelak VM; Whitworth NS; Norman PF; Cowan BD
Fertil Steril; 1989 Oct; 52(4):627-32. PubMed ID: 2806601
[TBL] [Abstract][Full Text] [Related]
13. Does transient hyperprolactinemia during ovarian hyperstimulation interfere with conception or pregnancy outcome?
Gonen Y; Casper RF
Fertil Steril; 1989 Jun; 51(6):1007-10. PubMed ID: 2721718
[TBL] [Abstract][Full Text] [Related]
14. Effects of metoclopramide-induced hyperprolactinemia during early follicular development on human ovarian function.
Kauppila A; Kirkinen P; Orava M; Vihko R
J Clin Endocrinol Metab; 1984 Nov; 59(5):875-81. PubMed ID: 6384260
[TBL] [Abstract][Full Text] [Related]
15. Effect of transitory hyperprolactinemia on in vitro fertilization of human oocytes.
Mendes MC; Ferriani RA; Sala MM; Moura MD; Carrara HH; de Sá MF
J Reprod Med; 2001 May; 46(5):444-50. PubMed ID: 11396370
[TBL] [Abstract][Full Text] [Related]
16. Follicular monitoring and outcome of in vitro fertilization in gonadotropin-releasing hormone-agonist-treated cycles.
Forman RG; Robinson J; Egan D; Ross C; Gosden B; Barlow DH
Fertil Steril; 1991 Mar; 55(3):567-73. PubMed ID: 1900482
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
[TBL] [Abstract][Full Text] [Related]
18. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist.
Younis JS; Matilsky M; Radin O; Ben-Ami M
Fertil Steril; 2001 Aug; 76(2):294-9. PubMed ID: 11476775
[TBL] [Abstract][Full Text] [Related]
19. The metoclopramid-provocation test for prediction of transient hyperprolactinemia during cycle stimulation.
Reinthaller A; Neunteufel W; Bieglmayer C; Fischl F
Fertil Steril; 1990 Feb; 53(2):368-71. PubMed ID: 2298320
[TBL] [Abstract][Full Text] [Related]
20. The influence of transient hyperprolactinemia on in vitro fertilization in humans.
Forman R; Fishel SB; Edwards RG; Walters E
J Clin Endocrinol Metab; 1985 Mar; 60(3):517-22. PubMed ID: 3919045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
